FDA Clearance Tracker · K261775
Uv Phototherapy (KN-4001A,KN-4001B,KN-4001AB)
Last checked: Nov 20, 2026Latest source record: Jul 21, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 21, 2026
Substantially Equivalent
Time to decision
53 days
Received May 29, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Not stated
The decision
- FDA number
- K261775
- Device name
- Uv Phototherapy (KN-4001A,KN-4001B,KN-4001AB)
- Applicant location
- Xuzhou, CN
- Received
- May 29, 2026
- Decided
- Jul 21, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- We could not check whether this was the first decision under its product code.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K261775
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Xuzhou Kernel Medical Equipment Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K242977 · Decided Feb 6, 2025 · 133 days after receipt
Device type: Light, Ultraviolet, Dermatological (FTC) · General & Plastic Surgery
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.